SecBot SecBot
COURT-RULING ·Filed Sep 2, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 1/10
Horizonimmediate Processed2mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This ruling has no material effect on Teva's stock. The underlying employment case is routine and the discovery dispute is procedural. No further monitoring is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$36.62
T+0 close · Sep 3, 2026 · via day close
Latest settled
+7.95%
T+20 · $39.53 · next T+60 in 13d
Vs SPY
+8.16%
α at T+20
Latest observation
+24.77%
T+49 · FF3 residual α
  1. T+0 · Sep 3 $36.62entry
  2. T+1 · 2mo ago −0.71%α −0.32% · $36.36
  3. T+5 · 2mo ago +1.28%α +2.43% · $37.09
  4. T+20 · 7w ago +7.95%α +8.16% · $39.53
  5. T+51 · todayOpen
  6. T+60 · in 13d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The court denied a pro se plaintiff's appeal of a magistrate judge's order requiring her to appear in person for a deposition in an employment-related lawsuit against Teva Pharmaceuticals USA, Inc. This is a routine discovery dispute with no financial exposure or business impact on Teva.

Court Ruling Details

Ruling Date
Sep 2, 2026
Court
United States District Court for the District of New Jersey
Court Level
District
Judge
Susan D. Wigenton
Case Type
employment
Ruling Type
procedural
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • The ruling is a denial of a pro se plaintiff's appeal of a discovery order regarding deposition format.
  • The case involves a routine employment dispute with no stated damages or business impact.
  • No financial figures, injunctions, or material business consequences are mentioned in the ruling.

Financial Impact

No financial impact, the ruling concerns only the logistics of a deposition in a routine employment case.

Risk Factors

  • No material risks identified from this ruling.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-20eb76d5ec-TEVA

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (10h 12m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Sep 3, 2026